Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 17176295)

Published in BJU Int on December 06, 2006

Authors

Matthew R Hotston1, Jamie Y Jeremy, Jonathan Bloor, Anthony Koupparis, Raj Persad, Nilima Shukla

Author Affiliations

1: Department of Urology, Bristol Royal Infirmary, Bristol, Avon, UK. matthotston@hotmail.com

Articles citing this

Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. J Sex Med (2008) 1.15

67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J Clin Invest (2013) 1.14

Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. J Urol (2008) 1.02

Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int (2009) 0.98

Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619. Prostaglandins Leukot Essent Fatty Acids (2008) 0.92

NADPH oxidase and the cardiovascular toxicity associated with smoking. Toxicol Res (2014) 0.91

Effects of tumor necrosis factor-alpha on sexual activity of male patients with ankylosing spondylitis. Clin Rheumatol (2014) 0.80

Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? Ther Adv Urol (2009) 0.78

NADPH oxidase: recent evidence for its role in erectile dysfunction. Asian J Androl (2008) 0.78

Long-term phosphodiesterase 5 inhibitor administration reduces inflammatory markers and heat-shock proteins in cavernous tissue of Zucker diabetic fatty rat (ZDF/fa/fa). Int J Impot Res (2015) 0.76

Sildenafil Ameliorates Advanced Glycation End Products-Induced Mitochondrial Dysfunction in HT-22 Hippocampal Neuronal Cells. J Korean Neurosurg Soc (2016) 0.75

Articles by these authors

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol (2010) 4.45

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS). BJU Int (2013) 1.87

A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. J Urol (2011) 1.84

Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer (2008) 1.73

The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol (2007) 1.62

The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. BJU Int (2008) 1.53

A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace. PLoS One (2013) 1.51

Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein. Ann Thorac Surg (2007) 1.48

Is it time to re-design the haematuria clinic? BJU Int (2009) 1.46

Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts. Eur J Cardiothorac Surg (2006) 1.46

HDR Brachytherapy in the Management of High-Risk Prostate Cancer. Adv Urol (2012) 1.45

Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg (2007) 1.39

Saphenous vein harvest with the Mayo extraluminal dissector: is endothelial function preserved? J Thorac Cardiovasc Surg (2008) 1.39

Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging (2012) 1.18

Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res (2008) 1.15

Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis (2006) 1.15

Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery. Br J Pharmacol (2004) 1.10

Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int (2005) 1.10

Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practising evidence-based medicine? BJU Int (2008) 1.06

Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells. Circulation (2004) 1.06

Towards the treatment of saphenous vein bypass graft failure--a perspective of the Bristol Heart Institute. Biorheology (2002) 1.03

Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg (2004) 1.01

Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress. J Cell Physiol (2011) 0.99

Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol (2004) 0.99

Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int (2009) 0.98

Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells. Br J Pharmacol (2005) 0.98

Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol (2005) 0.95

On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials (2006) 0.92

Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost. Eur J Pharmacol (2006) 0.92

Interactions between thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarization. Cardiovasc Res (2014) 0.92

A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study. J Thorac Cardiovasc Surg (2007) 0.90

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. Int J Cancer (2004) 0.90

Nicotinamide adenine dinucleotide phosphate oxidase: a promiscuous therapeutic target for cardiovascular drugs? Trends Cardiovasc Med (2005) 0.88

Differing levels of testosterone and the prostate: a physiological interplay. Nat Rev Urol (2011) 0.88

A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening. J Thorac Cardiovasc Surg (2004) 0.88

Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor. Prostate (2010) 0.88

Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor. Prostate (2009) 0.87

Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia. BJU Int (2013) 0.87

Macroscopic haematuria and urological cancer. Br J Gen Pract (2003) 0.86

Oxidative stress and vein graft failure: a focus on NADH oxidase, nitric oxide and eicosanoids. Curr Opin Pharmacol (2012) 0.86

Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation in the corpus cavernosum in the rabbit. BJU Int (2006) 0.85

The administration of folic acid improves erectile function and reduces intracavernosal oxidative stress in the diabetic rabbit. BJU Int (2008) 0.85

The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg (2004) 0.85

Nitric oxide donating aspirins: novel drugs for the treatment of saphenous vein graft failure. Ann Thorac Surg (2003) 0.84

Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit. Eur J Pharmacol (2006) 0.83

The trends in prostate specific antigen usage amongst United Kingdom urologists--a questionnaire based study. BMC Urol (2008) 0.83

NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells. J Cell Physiol (2012) 0.83

Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting. Ann Thorac Surg (2002) 0.83

The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer. BJU Int (2010) 0.83

Homocysteine and copper interact to promote type 5 phosphodiesterase expression in rabbit cavernosal smooth muscle cells. Asian J Androl (2008) 0.83

Pathophysiology of saphenous vein graft failure: a brief overview of interventions. Curr Opin Pharmacol (2012) 0.83

The administration of folic acid reduces intravascular oxidative stress in diabetic rabbits. Metabolism (2008) 0.82

Endothelin-1 (ET-1) and vein graft failure and the therapeutic potential of ET-1 receptor antagonists. Pharmacol Res (2010) 0.82

Differences in the epidemiology and presentation of prostate cancer in Black and White men in England: lessons learnt from the process study. BJU Int (2008) 0.81

Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1). J Thorac Cardiovasc Surg (2007) 0.81

Calcium and the replication of human vascular smooth muscle cells: studies on the activation and translocation of extracellular signal regulated kinase (ERK) and cyclin D1 expression. Eur J Pharmacol (2005) 0.81

Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England. BJU Int (2011) 0.80

NADPH oxidase 1 mediates upregulation of thromboxane A2 synthase in human vascular smooth muscle cells: inhibition with iloprost. Eur J Pharmacol (2011) 0.80

Is the therapeutic action of sildenafil mediated partly through the inhibition of superoxide formation? BJU Int (2005) 0.78

Incidence of bladder cancer in sri lanka: analysis of the cancer registry data and review of the incidence of bladder cancer in the South asian population. Korean J Urol (2012) 0.78

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening. Urology (2004) 0.78

Low nanomolar thapsigargin inhibits the replication of vascular smooth muscle cells through reversible endoplasmic reticular stress. Eur J Pharmacol (2013) 0.78

Re: Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J Urol (2006) 0.77

Cavernosal dysfunction in a rabbit model of hyperhomocysteinaemia. BJU Int (2005) 0.77

Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through differential effects on the expression of nitric oxide synthase and NADPH oxidase. Br J Pharmacol (2005) 0.77

Smoking and erectile dysfunction: the role of NADPH oxidase. BJU Int (2004) 0.77